Anxiety
Anxiety is a state of heightened physiological arousal and cognitive vigilance that the brain produces when it perceives threat. When the response is excessive, persistent, or out of proportion to the situation, it can meet criteria for an anxiety disorder.
Overview
Anxiety is the body’s normal threat-detection response. It activates the autonomic nervous system, sharpens attention, and prepares the body to act. In adaptive amounts, anxiety is useful: it motivates preparation, supports vigilance, and helps people respond to real risks. Anxiety becomes a clinical concern when it is excessive, persistent, difficult to control, and interferes with daily functioning.
The American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) groups anxiety disorders into a category that includes generalized anxiety disorder, panic disorder, social anxiety disorder, specific phobias, agoraphobia, separation anxiety disorder, and selective mutism. Each has distinct diagnostic criteria but shares the underlying feature of disproportionate fear or anxiety leading to behavioural disturbance.
Anxiety disorders are among the most common mental health conditions worldwide. The World Health Organization estimates that approximately 4% of the global population currently lives with an anxiety disorder, and the U.S. National Institute of Mental Health reports a lifetime prevalence in adults of approximately 31%. Onset is often in childhood or early adulthood, and women are diagnosed at roughly twice the rate of men, though this likely reflects both biological factors and differential help-seeking.
Anxiety presents along three interacting dimensions: physiological (rapid heart rate, muscle tension, gastrointestinal disturbance, shortness of breath), cognitive (intrusive worry, anticipatory thinking, difficulty concentrating, perceived loss of control), and behavioural (avoidance of feared situations, reassurance-seeking, safety behaviours, restlessness). Episodes vary widely in duration and intensity — some individuals experience steady chronic worry, others have discrete acute episodes such as panic attacks, and many fluctuate between the two.
Untreated anxiety is associated with measurable impairment: reduced occupational performance, relationship strain, sleep disturbance, and elevated risk for comorbid depression and substance use. It is also frequently comorbid with chronic medical conditions including cardiovascular disease, irritable bowel syndrome, and chronic pain, where the bidirectional relationship between physical and psychological symptoms can sustain both.
Recovery is well-evidenced. Anxiety disorders respond meaningfully to a range of evidence-based interventions, including cognitive behavioural therapy, acceptance and commitment therapy, exposure-based protocols, and several classes of medication. Most individuals who engage in treatment experience clinically significant reduction in symptom severity within twelve to sixteen weeks of structured intervention, and many achieve sustained remission.
Signs and symptoms
- Excessive worry — Persistent, hard-to-control anticipatory thinking about everyday events, often disproportionate to actual risk and lasting most days for at least six months.
- Restlessness or feeling on edge — A subjective sense of being keyed up, unable to settle, or unable to mentally relax even during downtime.
- Muscle tension — Sustained skeletal muscle tightness, often in the jaw, shoulders, neck, or lower back, frequently accompanied by tension headaches.
- Difficulty concentrating — Reduced ability to sustain attention or recall information, often described as the mind "going blank" under perceived pressure.
- Sleep disturbance — Difficulty falling asleep, frequent night waking, or unrefreshing sleep, often driven by intrusive worry at bedtime.
- Irritability — Heightened reactivity, low frustration tolerance, and quicker shifts to frustration than is typical for the individual.
- Autonomic arousal — Increased heart rate, sweating, trembling, dry mouth, or shortness of breath, sometimes occurring without identifiable trigger.
- Gastrointestinal disturbance — Nausea, abdominal discomfort, diarrhea, or appetite changes that track with stress or anticipatory periods.
- Avoidance behaviour — Active steering away from situations, places, or topics that have become associated with anxiety, often progressing to functional restriction over time.
- Anticipatory rumination — Repeated mental rehearsal of upcoming events, conversations, or possible failures, with the rehearsal failing to produce resolution.
Diagnostic context
In the DSM-5-TR, generalized anxiety disorder requires excessive anxiety and worry occurring more days than not for at least six months, about a number of events or activities, that the individual finds difficult to control. The disturbance must be associated with at least three of six specific physiological or cognitive symptoms (one in children) and cause clinically significant distress or impairment.
Other anxiety disorders — panic disorder, social anxiety disorder, agoraphobia, specific phobia, separation anxiety disorder, and selective mutism — have their own time-course and trigger criteria. Panic disorder, for example, requires recurrent unexpected panic attacks and a month or more of persistent concern about future attacks or related behavioural change. Social anxiety disorder requires marked fear or anxiety about social situations in which the person may be scrutinized.
Diagnosis is made by a qualified clinician through structured assessment, typically including clinical interview and review of symptom duration, frequency, triggers, functional impact, and rule-out of medical contributors. Self-report screening instruments such as the GAD-7 and PHQ-9 are useful for initial screening and treatment monitoring but are not sufficient for definitive diagnosis.
Causes and risk factors
Anxiety disorders arise from the interaction of biological, psychological, and environmental factors. No single cause has been identified, and the relative contribution of each factor varies between individuals.
Genetic and biological factors
First-degree relatives of individuals with anxiety disorders have an elevated rate of the same and related disorders, with twin studies estimating heritability between 30% and 50% depending on the specific disorder. Functional neuroimaging consistently shows heightened amygdala reactivity to threat cues and reduced top-down regulatory engagement from the prefrontal cortex in individuals with anxiety disorders. Dysregulation of serotonergic, noradrenergic, and gamma-aminobutyric acid (GABA) systems is implicated in symptom maintenance, which is the basis for several mainstream pharmacological treatments.
Temperamental factors
Behavioural inhibition in early childhood — a tendency to react with caution or avoidance to novel situations — is a well-established temperamental risk factor for later anxiety disorders. High trait neuroticism is similarly correlated.
Environmental factors
Adverse childhood experiences, including chronic stress, neglect, abuse, parental divorce, parental mental illness, and exposure to violence, increase later risk. Recent life stressors — bereavement, relationship breakdown, job loss, serious illness, financial precarity — frequently precede onset or exacerbation. Cultural and structural factors, including sustained discrimination and minority stress, are also recognized contributors.
Medical and substance contributors
Several medical conditions can present with anxiety as a primary symptom, including hyperthyroidism, cardiac arrhythmias, asthma, and chronic pain. Caffeine, stimulants, alcohol withdrawal, and certain medications can produce or amplify anxiety. A medical evaluation is appropriate when anxiety symptoms emerge suddenly in mid-life without obvious psychosocial trigger.
Anxiety disorders rarely have a single cause. Most cases involve a temperamental or genetic predisposition that is activated or sustained by environmental stress, and that is then maintained over time by patterns of avoidance, reassurance-seeking, or rumination.
Typical treatments
Anxiety disorders respond to a well-established range of evidence-based treatments. Selection depends on disorder type, severity, comorbidity, individual preference, and access.
Cognitive behavioural therapy (CBT) is the most extensively studied psychotherapy for anxiety disorders and is recommended as a first-line intervention by major treatment guidelines including those of the American Psychological Association and the U.K. National Institute for Health and Care Excellence (NICE). CBT addresses anxious cognitions and avoidance patterns through structured cognitive restructuring, behavioural experiments, and graded exposure. Treatment is typically delivered in 12 to 20 sessions.
Exposure-based therapy — including in-vivo, imaginal, and interoceptive exposure — is considered essential for anxiety disorders involving avoidance, particularly panic disorder, specific phobias, social anxiety disorder, and agoraphobia. Exposure works by repeatedly contacting the feared stimulus or sensation in a structured way, allowing the threat-detection system to update its predictions.
Acceptance and commitment therapy (ACT) is a widely used third-wave CBT variant that focuses on psychological flexibility, values-based action, and reduced experiential avoidance. It has comparable efficacy to traditional CBT in most randomized trials.
Pharmacotherapy. Several medication classes have demonstrated efficacy: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), buspirone, and (short-term, with caution) benzodiazepines. SSRIs and SNRIs are first-line for most anxiety disorders. Pharmacological decisions should be made with a physician or psychiatrist, taking medical history, side-effect profile, and pregnancy status into account.
Lifestyle and adjunctive interventions. Regular aerobic exercise, sleep regularization, reduction of caffeine and alcohol, and mindfulness-based stress reduction all have evidence supporting their use as adjuncts. They are not substitutes for first-line treatments in moderate-to-severe disorders.
Combined treatment. For moderate-to-severe presentations, evidence supports combining structured psychotherapy with pharmacotherapy. Outcomes are generally better than either modality alone for individuals with high baseline severity or significant comorbidity.
When to seek help
Professional consultation is warranted when anxiety symptoms persist most days for at least several weeks, when symptoms cause measurable interference with work, school, relationships, or daily functioning, or when anxiety is accompanied by significant avoidance that is restricting normal life activities. Earlier intervention is associated with better outcomes; chronic untreated anxiety tends to entrench rather than resolve.
Immediate medical attention is indicated for severe acute symptoms — sudden chest pain, fainting, or severe shortness of breath — to rule out medical conditions that can mimic anxiety. Mental health crisis services should be contacted when anxiety is accompanied by suicidal ideation, panic with persistent fear of losing control, or significant functional collapse.
In Canada, free 24-hour mental health support is available through 9-8-8: Suicide Crisis Helpline (call or text 988) and Talk Suicide Canada (1-833-456-4566). Provincial crisis lines and Health Link 811 (Alberta) provide additional triage. A general practitioner is an appropriate first contact for non-urgent mental health concerns and can provide referral to qualified psychologists, psychotherapists, or psychiatrists.
Frequently asked questions
Is anxiety the same as worry?
What causes anxiety?
Can anxiety be cured?
How is anxiety different from depression?
Is medication necessary to treat anxiety?
When should I see a doctor about anxiety?
References
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR).
- National Institute of Mental Health. Anxiety Disorders.
- World Health Organization. Anxiety disorders fact sheet.
- National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management (CG113).
- Bandelow, B., Michaelis, S., & Wedekind, D. (2017). Treatment of anxiety disorders. Dialogues in Clinical Neuroscience, 19(2), 93–107.
Find the pattern behind what's been feeling hard
A few simple questions to help surface the concerns that may fit best.
Find Your PatternTherapy for Anxiety
Connect with a ShiftGrit therapist at one of our locations:
Find a Therapist by Province
Browse therapy options by province to see which clinicians are available to work with clients in your region.
Trusted by Leading Psychology & Mental Health Organizations Across Canada
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.
Trusted By Alberta’s Leading Psychology & Mental Health Organizations
ShiftGrit Psychology & Counselling is professionally regulated, certified, and recognized by leading psychology and mental-health organizations across Alberta and Canada. These associations reflect our commitment to ethical practice, clinical standards, and evidence-informed therapy through Identity-Level Therapy and Reconditioning.










Regulated and affiliated across Alberta’s leading psychology, counselling, and mental-health organizations.
Regulated and affiliated across Canada’s leading psychology, counselling, and mental-health organizations.